Long-Term Treatment With Letrozole in a Boy With Familial Male-Limited Precocious Puberty

Xin Yuan1, Ruimin Chen1, Ying Zhang1, Xiaohong Yang1, Xiaoqin Lin1
1Department of Endocrinology, Genetics and Metabolism, Fuzhou Children’s Hospital of Fujian Medical University, Fuzhou, China

Tóm tắt

BackgroundThe long-term follow-up in children with familial male-limited precocious puberty (FMPP) who were treated with letrozole, triptorelin, and spironolactone is limited, especially considering the efficiency and safety.ObjectiveWe describe the clinical characteristics and long-term treatment with letrozole on adult height of a boy diagnosed with FMPP, confirmed by analysis of the LHCGR gene.MethodsPhysical examinations, bone age (BA), testosterone, and gonadotropin levels were measured as well as gene sequencing of the proband and parents.ResultsThe boy was referred to the hospital at 3.1 years of age due to peripheral precocious puberty. His height was 116.8cm (+5.1SD) and BA was 9 years. Genetic analysis revealed a patrilineal c.1703C>T.(p.Ala568Val) mutation of the LHCGR gene. After treating with letrozole for 1.6 years, the height according to BA went from -3.52SD to -2.82SD. Triptorelin was added at age 4.7 years based on both the evidence of central puberty and his growth velocity according to BA. During the 6.9 years of treatment, he had a height gain of 51.9cm, and BA increased 5.2 years. At age 10, his present height is 168.7cm (0.05SD) and BA is 14.7 years. No adverse effects of treatment were encountered.ConclusionA patrilineal mutation of the LHCGR gene has been identified in a boy with FMPP. His height is 168.7cm (-0.05SD) which is approaching his adult height after long-term treatment with letrozole, triptorelin, and spironolactone.

Từ khóa


Tài liệu tham khảo

Schoelwer, 2016, Treatment of Peripheral Precocious Puberty, Endocr Dev, 29, 10.1159/000438895

Fuqua, 2013, Treatment and Outcomes of Precocious Puberty: An Update, J Clin Endocrinol Metab, 98, 10.1210/jc.2013-1024

Özcabı, 2015, Testotoxicosis: Report of Two Cases, One With a Novel Mutation in LHCGR Gene, J Clin Res Pediatr Endocrinol, 7, 10.4274/jcrpe.2067

Lenz, 2010, Bicalutamide and Third-Generation Aromatase Inhibitors in Testotoxicosis, Pediatrics, 126, 10.1542/peds.2010-0596

Li, 2009, Height and Weight Standardized Growth Charts for Chinese Children and Adolescents Aged 0 to 18 Years, Zhonghua Er Ke Za Zhi, 47

Siviero-Miachon, 2017, Cosegregation of a Novel Mutation in the Sixth Transmembrane Segment of the Luteinizing/Choriogonadotropin Hormone Receptor With Two Brazilian Siblings With Severe Testotoxicosis, Endocr Res, 42, 10.1080/07435800.2016.1217005

Jeha, 2006, Variable Presentation of Precocious Puberty Associated With the D564G Mutation of the LHCGR Gene in Children With Testotoxicosis, J Pediatr, 149, 10.1016/j.jpeds.2006.03.017

Yoshizawa-Ogasawara, 2014, Third-Generation Aromatase Inhibitor Improved Adult Height in a Japanese Boy With Testotoxicosis, Clin Pediatr Endocrinol, 23, 10.1297/cpe.23.53

McGee, 2013, Precocious Puberty and Leydig Cell Hyperplasia in Male Mice With a Gain of Function Mutation in the LH Receptor Gene, Endocrinology, 154, 10.1210/en.2012-2179

Latronico, 2000, The Effect of Distinct Activating Mutations of the Luteinizing Hormone Receptor Gene on the Pituitary-Gonadal Axis in Both Sexes, Clin Endocrinol (Oxf), 53, 10.1046/j.1365-2265.2000.01135.x

Mao, 2010, A Report of Familial Male-Limited Precocious Puberty Caused by a Germ-Line Heterozygous Mutation (M398T) in Luteinizing Hormone Receptor Gene, Zhonghua Nei Ke Za Zhi, 49

Wang, 2017, Familial Male-Limited Precocious Puberty Due to Asp578His Mutations in the LHCGR Gene: Clinical Characteristics and Gene Analysis in an Infant, Zhongguo Dang Dai Er Ke Za Zhi, 19, 10.7499/j.issn.1008-8830.2017.11.007

Latronico, 1995, A Novel Mutation of the Luteinizing Hormone Receptor Gene Causing Male Gonadotropin-Independent Precocious Puberty, J Clin Endocrinol Metab, 80, 10.1210/jcem.80.8.7629248

Latronico, 2000, Gonadotropin-Independent Precocious Puberty Due to Luteinizing Hormone Receptor Mutations in Brazilian Boys: A Novel Constitutively Activating Mutation in the First Transmembrane Helix, J Clin Endocrinol Metab, 85, 10.1210/jcem.85.12.7071

Partsch, 2004, Long-Term Follow-Up of Spontaneous Development in a Boy With Familial Male Precocious Puberty, Horm Res, 62, 10.1159/000080887

Evans, 1996, A New Point Mutation in the Luteinising Hormone Receptor Gene in Familial and Sporadic Male Limited Precocious Puberty: Genotype Does Not Always Correlate With Phenotype, J Med Genet, 33, 10.1136/jmg.33.2.143

Babovic-Vuksanovic, 1994, Hazards of Ketoconazole Therapy in Testotoxicosis, Acta Paediatr, 83, 10.1111/j.1651-2227.1994.tb13192.x

Almeida, 2008, Long-Term Treatment of Familial Male-Limited Precocious Puberty (Testotoxicosis) With Cyproterone Acetate or Ketoconazole, Clin Endocrinol (Oxf), 69, 10.1111/j.1365-2265.2007.03160.x

Gupta, 2015, Drug Safety Assessment of Oral Formulations of Ketoconazole, Expert Opin Drug Saf, 14, 10.1517/14740338.2015.983071

Kreher, 2006, Treatment of Familial Male-Limited Precocious Puberty With Bicalutamide and Anastrozole, J Pediatr, 149, 10.1016/j.jpeds.2006.04.027

Eyssette-Guerreau, 2008, Effectiveness of Anastrozole and Cyproterone Acetate in Two Brothers With Familial Male Precocious Puberty, J Pediatr Endocrinol Metab, 21, 995, 10.1515/JPEM.2008.21.10.995

Wickman, 2001, A Specific Aromatase Inhibitor and Potential Increase in Adult Height in Boys With Delayed Puberty: A Randomized Controller Trial, Lancet, 357, 10.1016/S0140-6736(00)04895-9

Zhou, 2005, Letrozole Significantly Improves Growth Potential in a Pubertal Boy With Growth Hormone Deficiency, Pediatrics, 115, 10.1542/peds.2004-1536

Mauras, 2016, Randomized Trial of Aromatase Inhibitors, Growth Hormone, or Combination in Pubertal Boys With Idiopathic Short Stature, J Clin Endocrinol, 101, 10.1210/jc.2016-2891

Mitre, 2009, Treatment of Familial Male-Limited Precocious Puberty (Testotoxicosis) With Anastrozole and Bicalutamide in a Boy With a Novel Mutation in the Luteinizing Hormone Receptor, J Pediatr Endocrinol Metab, 22, 10.1515/JPEM.2009.22.12.1163

Reiter, 2010, Bicalutamide Plus Anastrozole for the Treatment of Gonadotropin-Independent Precocious Puberty in Boys With Testotoxicosis: A Phase II, Open-Label Pilot Study (BATT), J Pediatr Endocrinol Metab, 23, 999, 10.1515/jpem.2010.161

Wit, 2011, Aromatase Inhibitors in Pediatrics, Nat Rev Endocrinol, 8, 10.1038/nrendo.2011.161

Leschek, 2017, Effect of Antiandrogen, Aromatase Inhibitor, and Gonadotropin-Releasing Hormone Analog on Adult Height in Familial Male Precocious Puberty, J Pediatr, 190, 10.1016/j.jpeds.2017.07.047

Nabhan, 2019, TESTOTOXICOSIS WITH AN EPISODIC COURSE: AN UNUSUAL CASE WITHIN A SERIES, AACE Clin Case Rep, 5, 10.4158/ACCR-2018-0246

Neely, 2014, Letrozole vs Anastrozole for Height Augmentation in Short Pubertal Males: First Year Data, J Clin Endocrinol Metab, 99, 10.1210/jc.2014-2432